7:30AM Bacterin International's OsteoSponge product generates 'positive' clinical results (BONE) 1.42 : Co announces that the first clinical results using the OsteoSponge product for foot and ankle arthrodesis have been published in "The Journal of Foot & Ankle Surgery." The article reports a multi-center, retrospective analysis of 80 joint fusions in 47 subjects who had undergone foot and ankle fusion procedures utilizing OsteoSponge bone graft. Overall, a fusion rate of 97.5% (78 of 80 joints) was determined by radiographic analysis.
The article reported comparable or greater foot and ankle fusion rates, as judged radiographically, to that reported in the biomedical literature. Additionally, at 12-month post-operative assessment, the authors observed statistically significant improvements in function and pain alleviation at rates greater than those previously reported in biomedical studies.
Market Data 
Markets 
AI
